8-KEarnings & ResultsExhibits & Filings

ALNYLAM PHARMACEUTICALS, INC. 8-K Report, Financial Results (Aug 3, 2005)

Filed August 3, 2005For Securities:ALNY

Summary

This Form 8-K filing by Alnylam Pharmaceuticals, Inc. (ALNY) on August 3, 2005, primarily serves to announce the company's financial results for the quarter ended June 30, 2005. The key takeaway for investors is the reporting of these financial results, which are detailed in a press release furnished as Exhibit 99.1. While the filing itself does not provide the specific financial figures, it directs investors to the accompanying press release for a comprehensive overview of Alnylam's performance during the second quarter of 2005. Investors should review this press release for details on revenue, expenses, net income/loss, and any other material financial information relevant to understanding the company's operational and financial condition at that time.

Key Highlights

  • 1Alnylam Pharmaceuticals, Inc. filed a Form 8-K on August 3, 2005.
  • 2The report announces Alnylam's financial results for the quarter ended June 30, 2005.
  • 3The full text of the press release detailing these financial results is furnished as Exhibit 99.1.
  • 4The filing is made pursuant to Item 2.02 (Results of Operations and Financial Condition).
  • 5The information furnished is not considered 'filed' for certain SEC liability purposes, but is publicly available.
  • 6The CEO, John M. Maraganore, signed the report, indicating executive oversight.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly announce Alnylam Pharmaceuticals, Inc.'s financial results for the fiscal quarter that ended on June 30, 2005.

The detailed financial results are provided in the press release dated August 3, 2005, which is furnished as Exhibit 99.1 to this Form 8-K filing.

No, this Form 8-K filing itself does not contain the specific financial figures. It directs investors to the accompanying press release (Exhibit 99.1) for those details.

The filing explicitly states that the information in this Form 8-K (including Exhibit 99.1) shall not be deemed 'filed' for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, unless specifically incorporated by reference into another SEC filing.